16.11.2022
А. Н. КУЛИКОВ; Н. В. МУРАВЬЕВА; Б. С. БЕЛОВ
of developing COVID-19. Vaccination is an effective method of preventing this disease, which may be unsafe
19.10.2022
Е. С. Аронова; Б. С. Белов; Г. И. Гриднева
that in patients previously infected with EBV, COVID-19 can cause its reactivation, which is often manifested
09.09.2022
Б. С. БЕЛОВ; Н. В. МУРАВЬЕВА; А. Н. КУЛИКОВ
The problem of coronavirus disease 2019 (COVID-19) still remains relevant even now, after two
06.07.2022
Н. В. Муравьева; Б. С. Белов
in the pathogenesis of COVID-19, which is confirmed by the results of numerous studies. However, data on the efficacy
04.05.2022
Б. С. Белов; Т. В. Попкова; Г. М. Тарасова; Н. В. Муравьева
by influenza viruses, hepatitis B, Herpes zoster, human papilloma viruses, COVID-19 and pneumococcus
13.03.2022
Е. С. Аронова; Б. С. Белов; Г. И. Гриднева
the course of PCS in rheumatic diseases
Purpose. To characterize the features of the course of COVID-19
27.02.2022
Б. С. Белов; А. М. Лила; Е. Л. Насонов
The problem of coronavirus disease 2019 (Coronavirus diseases, COVID-19) two years later still
17.02.2022
А. Н. Куликов; Н. В. Муравьева; Б. С. Белов
Objective: to assess the safety of COVID-19 vaccines in patients with immunoinflammatory rheumatic
26.12.2021
Е. Л. Насонов; Б. С. Белов; А. М. Лила; Е. С. Аронова; Г. И. Гриднева; А. В. Кудрявцева; Е. В. Сокол; А. В. Торгашина; И. Б. Виноградова; Д. И. Абдулганиева; А. Ю. Зименко
The materials of the Russian NIIR/ARP-COVID-19 database, which included adult (over 18 years old
30.11.2021
Б. С. Белов; Н. В. Муравьева; М. М. Баранова
infections, viral hepatitis B, yellow fever and COVID-19 used in rheumatological patients. It has been shown
